← All companies
ApoGlyx
We are developing aquaporin inhibitor technology for pharmaceutical treatments of sepsis and diabetes
📍 Lund, Skåne
Stats
- Employees (LinkedIn)
- 5
- Size bucket
- 1 employee
- Followers
- 270
- Founded
- 2015
- Org type
- Privately Held
- Country
- SE
- LinkedIn ID
- 15153523
- Slug
- apoglyx
Industries
Biotechnology Research
Specialties
AquaporinBiotechnologyDrug DiscoverySepsisand Type 2 diabetes
About
Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
Locations (1)
- Medicon Village, Lund, Skåne 22381, SE